Loading clinical trials...
Loading clinical trials...
This study will assess the efficacy, safety and pharmacokinetics of certoparin when used to prevent clotting during hemodialysis.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Novartis
NCT06376968 · Renal Dialysis
NCT05755503 · Uremic; Toxemia, Pharmacokinetics, and more
NCT05161078 · Acute Kidney Injury, Chronic Kidney Diseases, and more
NCT06584734 · Renal Dialysis, Hemodiafiltration, and more
NCT07312929 · Renal Dialysis, Renal Replacement Therapy, and more
Novartis Investigative Site Darmstadt
Darmstadt
Novartis Investigative Site Elsenfeld
Elsenfeld
Novartis Investigative Site Flensburg
Flensburg
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions